secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001140361-26-016764
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Opus Genetics closes $35 million initial tranche of $155 million senior secured notes
--------------------------------------------------------------------------------

- Initial $35 million tranche funded on April 21, 2026; notes mature April 21, 2033.
- Notes bear floating rate based on Term SOFR (with floor) plus margin; interest payable quarterly.
- Total note purchase agreement provides up to $155 million ($105M committed, $50M uncommitted).
- Notes secured by substantially all assets of Opus Genetics and its subsidiaries.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036126016764/0001140361-26-016764-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036126016764/ef20071455_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-016764

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer